NMN IV Therapy (600mg)

Mid-range NMN intravenous infusion delivering 600mg of nicotinamide mononucleotide for patients who have tolerated lower doses and seek a more concentrated NAD+ precursor delivery. This dose is positioned for ongoing maintenance in patients pursuing age-related NAD+ replenishment strategies.

The 600mg NMN IV infusion at TGWAC represents a significant step up from the introductory 200mg dose, delivering three times the concentration of nicotinamide mononucleotide in a single session. This dose is typically recommended for patients who have completed an initial course at the lower level and demonstrated good tolerance, or for those with physician guidance based on NAD+ level testing. At this concentration, the infusion takes approximately 60 minutes to administer safely, with the NMN solution delivered at a controlled rate to allow steady absorption and minimise any transient flushing or warmth that some patients report at higher doses. The clinic monitors vitals before, during, and after the session. NAD+ is required by over 500 enzymatic reactions in the human body, including those governed by sirtuins — a family of proteins implicated in cellular stress resistance, inflammation regulation, and metabolic homeostasis. By providing a concentrated bolus of the immediate NAD+ precursor, IV NMN therapy aims to elevate intracellular NAD+ levels more effectively than oral routes, where bioavailability is estimated at 20-30% of the ingested dose. The clinic positions the 600mg dose as a maintenance protocol, with sessions typically scheduled every two to four weeks depending on patient goals and baseline NAD+ measurements. Some patients combine NMN infusions with other IV therapies available at TGWAC — such as high-dose vitamin C or Myers Cocktail — as part of a broader longevity programme designed with their attending physician. Patients interested in the 600mg dose are encouraged to complete at least two sessions at the 200mg level first. The clinic tracks outcomes through periodic NAD+ level assessments and patient-reported markers including energy, sleep quality, and cognitive clarity.